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Down-regulation of rat organic cation transporter rOCT2 by and reabsorption. The proximal tubular cells play a piv-
5/6 nephrectomy. otal role in limiting or preventing toxicity by secreting
Background. In rat kidneys, the organic ion transporters organic anions and cations actively from the circulationrOCT1, rOCT2, rOAT1 and rOAT3 are considered to mediate
into the urine [1–3]. Recently, renal basolateral typesthe basolateral uptake of various ionic compounds. However,
their changes in chronic renal failure (CRF) are poorly under- of organic anion transporters, rOAT1 and rOAT3, and
stood. The present study examined the renal handling of or- organic cation transporters, rOCT1 and rOCT2, have
ganic ions and the expression of these transporters under CRF. been cloned and characterized [4–7]. These transportersMethods. 5/6 Nephrectomized rats were used as the animal
have been suggested to mediate the basolateral entry ofmodel of CRF. Renal handlings of cimetidine and paraamino-
hippuric acid (PAH) were examined by in vivo experiments. various anionic or cationic drugs into the proximal tubu-
rOAT1, rOAT3, rOCT1 and rOCT2 expressions were deter- lar epithelial cells. Therefore, the functional and molecu-
mined by Western blotting. lar changes in these organic ion transporters would resultResults. The tubular secretion rates of both PAH and cimeti-
in impaired renal excretion of drugs, thereby causingdine were markedly decreased in CRF rats. Although the distri-
unexpected adverse effects of administered ionic drugs.bution rates of PAH into the kidney cortex and medulla, and
of cimetidine into the kidney cortex were maintained, the distri- As renal ablation results in proteinuria, functional hy-
bution rate of cimetidine into the kidney medulla was signifi- pertrophy and progressive kidney disease in the rat [8],
cantly decreased in CRF rats. The expression level of the
5/6 nephrectomized (5/6 Nx) rats have been widely usedrOCT2 protein was markedly depressed in CRF rats, but those
to study the progression of renal damage. There haveof rOCT1, rOAT1 and rOAT3 were maintained. In addition,
the plasma concentration of testosterone, a regulator of rOCT2 been various reports concerning the mechanisms of glo-
expression, was significantly reduced by CRF. Both the renal merular dysfunction in remnant nephrons [8, 9]. Re-
clearance of cimetidine and rOCT2 expression were recovered
cently, renal tubule dysfunction has also been reportedby the exogenous administration of testosterone in CRF rats.
in chronic renal failure (CRF). Kwon et al reported thatConclusions. The levels of urinary excretion of cationic
drugs, especially substrates for rOCT2, were reduced under the levels of expression of aquaporin water channels
CRF partly due to the reduced expression of rOCT2, and (AQP1, AQP2 and AQP3) were decreased in CRF [10].
the lowered plasma level of testosterone was suggested to be
In addition, it was reported that there were significantresponsible for the depressed rOCT2 expression in CRF.
decreases in total kidney levels of proximal tubular so-
dium transporters such as the type 3 Na/H exchanger
(NHE-3) in rats with CRF [11]. Tubular adenosine 5-tri-Numerous organic anions and cations including en-
phosphate (ATP)-driven multispecific organic aniondogenous substances, xenobiotics and their metabolites
transporter MRP2 has been shown to be up-regulatedare excreted from the body. The kidney is critical for
in 5/6 Nx rat kidneys [12]. It is generally acknowledgedthe elimination of ionic drugs, as well as the liver. The
that some ionic drugs should be used in lower dosagesnet excretion of drug into urine is defined basically by
or with longer inter-dose intervals to prevent adversethree processes: glomerular filtration, tubular secretion
effects in CRF. As circulating organic ions show exten-
sive accumulation into the tubular epithelial cells via
Key words: cimetidine, p-aminohippuric acid, chronic renal failure, OAT1, OAT3, OCT1 or OCT2 [13], information regard-renal clearance, organic anion transporter, testosterone, remnant
kidney. ing changes in these transporters in CRF would be useful
to determine optimal use of drugs in progressive renal
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METHODS ton Dickinson and Co., Parsippany, NJ, USA) filled with
heparin solution (100 U/mL) for blood sampling andExperimental animal
drug administration, respectively. Urine was collectedFor ablation of the renal mass, male Wistar albino rats
from the urinary bladder catheterized with PE-50 tubing.(200 to 220 g) were anesthetized with sodium pentobarbi-
Thereafter, PAH or cimetidine was administered as atal (40 mg/kg) and the kidneys were exposed under asep-
bolus via the femoral vein and incorporated into infusiontic conditions via a ventral abdominal incision. The right
solution as described [15]. The respective loading andkidney was removed, and the posterior and anterior api-
maintenance doses of the drugs including 4% mannitolcal segmental branches of the left renal artery were indi-
were as follows: 30 mol/kg and 55 mol/mL for PAH,vidually ligated, and the abdominal incision was closed
and 317 mol/kg and 21.8 mol/mL for cimetidine. Thewith 4-0 silk sutures. In the sham-operated animals, the
infusion rate was 2.2 mL/h using an automatic infusionperitoneal cavity was exposed, and both kidneys were
pump (Natsume Saisakusho, Tokyo, Japan). Mannitolgently manipulated. After surgery, animals were allowed
was used to maintain sufficient and constant urine flowto recover from anesthesia and surgery in cages with
rate. After a 30-minute equilibration period, urine sam-free access to water and standard rat chow for two weeks.
ples were collected three times at ten minute intervals,To examine the effects of exogenous administration
and blood samples were obtained at the midpoint ofof testosterone on the drug pharmacokinetics and the
urine collection. The plasma was immediately separatedrenal expression of transporters, another batch of ani-
from erythrocytes by centrifugation. At the end of themals with or without 5/6 Nx was used. Because Anderson
experiment, an adequate volume of blood was collectedet al reported that the plasma elimination half-life of
from the abdominal aorta to examine the plasma proteintestosterone after the single administration of the un-
modified testosterone and the esterified testosterone- binding rate, and the kidneys were removed to determine
17-heptanoic acid (testosterone enanthate) to be 2.0 the tissue concentrations of PAH and cimetidine and
and 51 hours in adult female rats, respectively [14], we the expression of renal drug transporters. The concentra-
chose the latter compound for the following experiments. tions of PAH and cimetidine in plasma, urine and renal
First, the sham-operated and 5/6 Nx rats were adminis- homogenate were determined by high-performance liq-
tered a subcutaneous injection of testosterone [0.5 mg uid chromatography (HPLC) [16, 17]. The plasma un-
testosterone enanthate (T) dissolved in 200 L corn oil/ bound fraction (fu) of PAH or cimetidine was deter-
rat, T()] or vehicle [200 L corn oil/rat, T()] at 1, 4, mined by ultrafiltration using a micropartition system
7, 10, 13 days after surgery, respectively. Except for the (MRS-1; Amicon, Inc., Beverly, MA, USA), as described
subcutaneous administration of testosterone every three earlier [15]. The free fraction of PAH or cimetidine was
days, animals were allowed access to water and standard expressed as the ratio of the concentration in the ultrafil-
rat chow for two weeks. trate to that in plasma.
Rats were maintained in metabolic cages for 24 hours
before the in vivo experiment to determine urine output Tissue distribution of PAH and cimetidine
and urinary levels of creatinine and albumin. The blood [14C]PAH (1.9 GBq/mmol) and [3H]cimetidine (814
urea nitrogen (BUN) was determined by the urease/
GBq/mmol) were obtained from DuPont-New England
indophenol method. The levels of creatinine in serum
Nuclear Research Products (Boston, MA, USA). 5/6 Nxand urine were determined by Jaffe´ reaction. For mea-
and sham rats were anesthetized with sodium pentobar-surement, we used assay kits from Wako Pure Chemical
bital. Tracer amounts of [14C]PAH (1 mol/kg, 20 kBq/Industries (Osaka, Japan). The concentrations of plasma
mL) or [3H]cimetidine (1.3 nmol/kg, 20 kBq/mL) wereand urinary albumin were measured using an ELISA kit
administered as a bolus via the catheterized right femoral(NEPHRAT II; Exocell, Inc., Philadelphia, PA, USA).
vein. Blood samples were collected at 0.5, 1, 1.5, 2, 2.5Plasma testosterone and 17-estradiol levels were mea-
and 3 minutes from the left femoral artery. The plasmasured with an enzyme immunoassay kit (Cayman Chemi-
was immediately separated from erythrocytes by centrif-cal Co., Ann Arbor, MI, USA). The animal experiments
ugation. Three minutes after injection, several tissuewere performed in accordance with the Guidelines for
specimens were collected immediately after sacrificing ratsAnimal Experiments of Kyoto University.
[18]. The excised tissues were gently washed, weighed
Infusion experiment and homogenized in 3 volumes of 0.9% NaCl. Aliquots
(100 L) of blood and tissue homogenates were solubi-5/6 Nephrectomized rats and sham-operated controls
lized in 0.5 mL of NCS2 (Amersham Pharmacia Biotech,were anesthetized by intraperitoneal (IP) administration
Uppsala, Sweden), and the radioactivity was determinedof 50 mg/kg sodium pentobarbital. Catheters were in-
in 5 mL of ACS2 (Amersham) by liquid scintillationserted into the right femoral artery and the left femoral
vein with polyethylene tubing (Intramedic PE-50; Bec- counting.
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Table 1. Renal functional data in ratsAnalytical methods
Sham 5/6 NxFor infusion experiments, pharmacokinetic parame-
Body weight g 300.08.1 267.15.9ters were calculated using standard procedures for each
Urine volume mL/24 h 23.52.9 36.53.2aexperimental period. The total plasma clearance (Ctp) PCr mg/dL 0.790.02 1.330.07awas calculated by dividing the infusion rate by the steady- CCr mL/min/kg 3.690.31 1.960.17a
BUN mg/dL 16.00.8 51.55.1astate plasma concentration (Cpss) at the midpoint of urine
Palb mg/dL 90.84.7 49.46.0acollection. Renal clearance (Cren) was obtained by divid- Ualb lg/min/kg 0.850.32 42.97.8aing the urinary excretion rates by Cpss. The renal clear-
Values are meansSE of twelve rats. Abbreviaitons are: PCr, plasma creati-ance of unbound PAH or cimetidine (Cr.f) was deter- nine; CCr, creatinine clearance; BUN, blood urea nitrogen; Palb, plasma albumin;
Ualb, urinary albumin; Sham, sham-operated rats; 5/6 Nx, 5/6 nephrectomizedmined by dividing Cren by the unbound fraction (fu) of
rats.
PAH or cimetidine, respectively. The glomerular filtra- aP  0.01, significantly different from sham-operated rats
tion rate (GFR) was assumed to be equal to the Cren of
creatinine. The renal secretory clearance of unbound
PAH or cimetidine was calculated by subtracting GFR
state Biotechnology Inc., Lake Placid, NY, USA), orfrom Cr.f. For tissue distribution experiments, the tissue
antibody preabsorbed with the synthetic antigen peptideuptake clearance of PAH and cimetidine were calculated
(10 g/mL) for rOAT1 or rOAT3. The blots wereby dividing the tissue accumulation at three minutes by
washed three times with PBS-T, and the bound antibodythe area under the plasma concentration-time curve until
was detected on X-ray film by enhanced chemilumines-three minutes (AUC0-3min). cence (ECL) with horseradish peroxidase conjugated
secondary antibodies and cyclic diacylhydrazides (Amer-Polyclonal antibodies against rOAT1 and rOAT3
sham). The relative amounts of the bands in each lanePolyclonal antibodies were raised against the synthetic
were determined densitometrically using NIH image 1.61peptide corresponding to the intracellular domains near
(National Institutes of Health, Bethesda, MD, USA),the COOH-terminal of rOAT1 (QQKQMMPLQAST
and the densitometric ratios to each control [Sham or
QEKNGL) or rOAT3 (SEAEKASQIIPLKTGG), re-
Sham T()] were used as the reference and accorded
spectively. The peptides were synthesized with cysteine
an arbitrary value of 1.0, respectively.
at the NH2-terminal. After obtaining pre-immune serum,
rabbit antiserum was raised against the peptide con- Statistical analysis
jugated to keyhole limpet hemocyanin (Calbiochem- All data are expressed as means  SE. Data of West-
Behring, La Jolla, CA, USA). Male New Zealand White ern blot analysis are expressed in arbitrary units of
rabbits (2.2 to 2.5 kg) were immunized with 1 mL of densitometry/25 g protein. Comparisons between the
conjugates (1 mg of the peptide for rOAT1 or rOAT3) sham-operated and 5/6 Nx rats were performed using
emulsified with Freund’s complete adjuvant. Booster in- the unpaired t test. P  0.05 was considered significant.
jections of the emulsified conjugates were given every
two weeks until the antibodies were obtained. After each
RESULTSbooster injection, blood was collected and antibody pro-
duction was determined by enzyme-linked immunosor- Renal functional data of 5/6 Nx rats
bent assay (ELISA). 5/6 Nephrectomized rats showed renal insufficiency.
As shown in Table 1, the body weights tended to be
Western blot analysis lower and 24-hour urine volume was markedly increased
The crude plasma membrane fractions were prepared in 5/6 Nx rats. The levels of BUN and urinary albumin
from rat kidneys, as described previously [19]. The crude were significantly increased, and the creatinine clearance
plasma membrane fractions were separated by 10% so- and plasma albumin were markedly decreased in 5/6 Nx
dium dodecyl sulfate-polyacrylamide gel electrophoresis rats in comparison with sham-operated rats.
(SDS-PAGE) and transferred onto polyvinylidene di-
Urinary secretion of PAH and cimetidine under CRFfluoride (PVDF) membranes (Immobilon-P; Millipore,
Bedford, MA, USA) by semi-dry electroblotting. The Table 2 shows the pharmacokinetic parameters of
blots were blocked with 5% non-fat dry milk and 5% PAH and cimetidine after intravenous infusion in sham-
bovine serum albumin in phosphate-buffered saline (PBS, operated and 5/6 Nx rats. The plasma concentrations of
137 mmol/L NaCl, 3 mmol/L KCl, 8 mmol/L Na2HPO4, PAH and cimetidine in 5/6 Nx rats were threefold and
1 mmol/L KH2PO4, 12 mmol/L K2HPO4, pH 7.5) con- 1.7-fold higher than those in sham-operated controls,
taining 0.5% Tween 20 (PBS-T), and incubated over- respectively. The renal clearance of PAH or cimetidine
night at 4C with primary antibody specific for rOAT1, occupied 100% or 81% of each total plasma clearance
in sham-operated rats, respectively. However, the contri-rOAT3, rOCT1 [20], rOCT2 [21], Na/K-ATPase (Up-
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Table 2. Pharmacokinetic parameters of PAH and cimetidine after intravenous infusion in rats
PAH Cimetidine
Sham 5/6 Nx Sham 5/6 Nx
Cpss lmol/L 24221 708123b 16018 27219b
fu 0.860.02 0.930.03 0.860.05 0.770.05
Ctot mL/min/kg 29.12.0 11.91.8b 17.21.9 10.90.5b
Cren mL/min/kg 29.12.1 9.22.0b 14.01.5 2.20.5b
Cren of unbound fraction
mL/min/g kidney 5.40.6 2.70.8a 2.50.2 0.70.1b
Kp 2.00.2 1.60.3 2.30.1 1.20.2b
Each value represents the meanSE of six rats. Abbreviaitons are: Cpss, plateau plasma concentration; Ctot, total clearance; Cren, renal clearance; fu, plasma
unbound fraction; Kp, tissue-to-plasma concentration ratio; PAH, p-aminohippuric acid; Sham, sham-operated rats; 5/6 Nx, 5/6 nephrectomized rats.
aP  0.05, bP  0.01, significantly different from sham-operated rats
Fig. 1. Renal secretory clearance of unbound
paraaminihippurate (PAH; A) and cimetidine
(B ). PAH (55 mol/mL) or cimetidine (21.8
mol/mL) was infused at a rate of 2.2 mL/h
using an automatic infusion pump. The renal
secretory clearance of unbound PAH or ci-
metidine was calculated by subtracting GFR
from the renal clearance of unbound PAH
or cimetidine. Each column represents the
mean  SE of six rats. *P  0.05; **P  0.01,
significantly different from the sham-operated
controls. Abbreviations are: Sham, sham-op-
erated rats; 5/6 Nx, 5/6 nephrectomized rats.
bution of the kidney to the excretion of PAH or cimeti- [14C]PAH and [3H]cimetidine to three minutes after in-
travenous administration are shown in Figure 2. Thedine in 5/6 Nx rats was significantly reduced to 74% or
19%, respectively. The total plasma clearance of both AUC0-3 min of [14C]PAH and [3H]cimetidine were 45.9 
3.1 and 25.1  1.7 in sham-operated rats, and 102.7 PAH and cimetidine were significantly decreased in 5/6
Nx rats compared with those in sham-operated controls. 17.7 and 49.8  8.4 in 5/6 Nx rats (mean  SE, N 	 6),
respectively. Table 3 shows the tissue concentrations andThe renal clearance of PAH in 5/6 Nx rats was markedly
decreased to 32% in comparison with that in sham-oper- Kp value of [14C]PAH and [3H]cimetidine in sham-oper-
ated and 5/6 Nx rats. The calculated tissue uptake clear-ated rats, and the renal clearance of cimetidine in 5/6
Nx rats was also markedly reduced to 16% of that in the ance of [14C]PAH and [3H]cimetidine in sham-operated
and 5/6 Nx rats are illustrated in Figure 3. The Kp valuesham-operated controls. The renal clearance of unbound
PAH and cimetidine (mL/min/g kidney) was significantly and the tissue uptake clearance indicated that both
[14C]PAH and [3H]cimetidine were markedly accumu-decreased to 50% and 28% of those in sham-operated
rats, respectively. Although the tissue-to-plasma concen- lated in the kidney. The concentration, Kp values and
tissue uptake clearance of PAH in the kidney cortex andtration ratio (Kp) of PAH was not significantly decreased
in the 5/6 nephrectomized rat kidneys, the Kp value of medulla were slightly decreased by the 5/6 Nx, but these
effects were not significant. Although the concentrationcimetidine was markedly reduced to 50% in comparison
with that in the sham-operated rat kidneys. The tubular and the tissue uptake clearance of cimetidine in the kid-
ney cortex were maintained in 5/6 Nx rats, the Kp valuesecretory clearance of PAH and cimetidine were mark-
edly decreased to 44% and 14% of those in sham-oper- was decreased to 60% of sham-operated control. In con-
trast, the concentration, Kp value and tissue uptakeated controls, respectively (Fig. 1).
clearance of cimetidine in the kidney medulla were
Tissue distribution of PAH and cimetidine markedly reduced by 5/6 nephrectomy to 62%, 34%
and 39%, respectively. The concentrations of PAH andThe initial PAH and cimetidine uptake were deter-
mined in various tissues. The plasma concentrations of cimetidine in the small intestine were significantly in-
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Fig. 2. Plasma concentration curves of PAH
(A) and cimetidine (B ) in rats after intrave-
nous injection. [14C]PAH (1 mol/kg) or
[3H]cimetidine (1.3 nmol/kg) was adminis-
tered as a bolus via the right femoral vein of
() sham-operated or () 5/6 nephrecto-
mized rats. Blood samples were collected from
the left femoral artery at 0.5, 1, 1.5, 2, 2.5 and
3 min after the injection. Each point repre-
sents the mean  SE of six rats. *P  0.05;
**P  0.01, significantly different from sham-
operated controls.
Table 3. Tissue distributions of PAH and cimetidine 3 minutes after intravenous bolus administration in rats
PAH Cimetidine
Sham 5/6 Nx Sham 5/6 Nx
Plasma or Concentration Concentration Concentration Concentration
tissues lmol/L Kp lmol/L Kp nmol/L Kp nmol/L Kp
Plasma 2.10.1 1 4.80.7b 1 1.40.1 1 2.30.2b 1
Brain 0.10.0 0.00.0 0.20.1 0.10.0 0.10.0 0.10.0 0.50.2 0.20.1
Liver 1.50.1 0.70.1 1.70.2 0.40.0b 6.40.5 4.70.2 8.62.0 3.60.5
Small intestine 0.50.1 0.20.0 0.70.1a 0.20.0 2.20.2 1.60.1 3.60.6a 1.50.2
Kidney cortex 28.38.5 12.83.3 36.37.1 7.91.7 28.13.7 20.52.0 28.46.5 12.42.6a
Kidney medulla 38.211.5 17.54.8 36.410.6 7.82.5 58.97.0 43.74.7 36.69.4 14.93.7b
Each value represents the meanSE of six rats. Abbreviations are: Kp, tissue-to-plasma concentration ratio; PAH, p-aminohippuric acid; Sham, sham-operated
rats; 5/6 Nx, 5/6 nephrectomized rats
aP  0.05, bP  0.01, significantly different from sham-operated rats.
creased in 5/6 Nx rats, but the Kp values for both drugs of sham-operated rats; P  0.05, N 	 7), whereas there
were no significant differences in the expression ofwere maintained. The Kp value and the tissue uptake
clearance of PAH in the liver were decreased to 57% rOAT1, rOAT3, rOCT1 or Na/K-ATPase between
the sham-operated and 5/6 Nx rat kidneys.and 70% of those in sham-operated rats, respectively.
Protein expression of organic ion transporters in Plasma levels of testosterone and 17-estradiol in
5/6 Nx rats5/6 Nx rats
To obtain more information about the decreases in Our previous study found that the renal expression
level of rOCT2 was regulated by the plasma concentra-renal elimination of PAH and cimetidine in the 5/6 Nx
rats in comparison with those in sham-operated controls, tion of testosterone: higher plasma concentrations of
testosterone were associated with higher level of renal ex-we assessed renal organic ion transporters expression at
the protein level by Western blotting. As shown in Figure pression of rOCT2 protein [21, 22]. To examine whether
the decreased expression level of renal rOCT2 was asso-4A, a primary band for rOAT1 or rOAT3 with a size of
77 kD (calculated molecular weight of 61 kD) or 72 kD ciated with the plasma level of testosterone, we measured
the plasma concentrations of testosterone and 17-estra-(calculated molecular weight of 59 kD) was detected,
respectively. The preabsorption of each antibody with diol in 5/6 Nx rats in comparison with those in sham-
operated controls. As shown in Table 4, the plasma con-corresponding antigen peptide abolished these positive
bands, showing the presence of rOAT1 and rOAT3 pro- centration of testosterone in 5/6 Nx rats was significantly
decreased in comparison with that in sham-operated con-teins in the rat kidney. As illustrated in Figure 4 B and
C, the protein expression level per 25 g of renal crude trols. In contrast, there was no difference in the plasma
concentration of 17-estradiol between the 5/6 Nx andplasma membrane protein fractions of rOCT2 was mark-
edly depressed in the 5/6 Nx rat kidneys (33.3  7.0% sham-operated rats.
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testosterone was twofold higher in the Sham T() rats,
threefold lower in the 5/6 Nx T() rats and 1.5-fold
higher in the 5/6 Nx T() rats than that in the Sham
T() rats, respectively. The values of the urine volume
during 24 hours, plasma creatinine (PCr), creatinine clear-
ance (CCr) and BUN values were not affected by the
administration of testosterone in the 5/6 Nx rats. How-
ever, the body weight loss in the 5/6 Nx rats was relatively
ameliorated by the testosterone treatment. In addition,
the plasma level of creatinine in the Sham T() was
significantly lowered than in the Sham T() rats. Table
6 showed the pharmacokinetic parameters of cimetidine
in infusion experiment after administration of testoster-
one in rats. Although there were no significant differ-
ences in the pharmacokinetic parameters such as Cpss,
Ctp, Cren, Cr.f, Kp and tubular secretory clearances of ci-
metidine between the Sham T() and the Sham T()
rats, all these parameters were significantly ameliorated
by the administration of testosterone in the CRF rats.
In particular, the Cr.f value in the 5/6 Nx T() rats recov-
ered to almost 80% of that in the sham-operated rats.
Additionally, the protein expression level of rOCT2 in
5/6 Nx rats recovered to around the sham-operated rats’
value by the exogenous testosterone treatment (Fig. 5A).
Furthermore, the protein expression level per 25 g of
renal crude plasma membrane protein fractions of
rOCT2 correlated well with the Cr.f of cimetidine (Fig.
5B). However, the expression levels of rOAT1, rOAT3,
rOCT1 and Na/K-ATPase were not affected by the
administration of testosterone in the CRF rats as well
as the sham-operated rats (Fig. 6).
DISCUSSIONFig. 3. Tissue uptake clearance of PAH (A) or cimetidine (B ) in ()
sham-operated or () 5/6 nephrectomized rats. Three minutes after Renal organic anion transporters, rOAT1 and rOAT3,
bolus administration of [14C]PAH (1 mol/kg) or [3H]cimetidine (1.3 and organic cation transporters, rOCT1 and rOCT2,nmol/kg) via the right femoral vein, the tissues were harvested. The
have been cloned and characterized [4–7]. These trans-concentration of PAH or cimetidine in each tissue was measured.
The tissue uptake clearance of PAH or cimetidine was calculated by porters are localized in the basolateral membranes of
dividing the tissue concentration at 3 min with AUC0-3min from each proximal tubules, and have been suggested to mediaterat. Each column represents the mean  SE of six rats. *P  0.05;
basolateral uptake of various ionic compounds. rOAT1**P  0.01, significantly different from sham-operated controls.
and rOAT3 recognize anionic compounds such as PAH,
nonsteroidal antiinflammatory drugs, methotrexate, loop
diuretics, acetazolamide, cephalosporins, uric acid and
Effect of exogenous testosterone on pharmacokinetics prostaglandin E2 [4, 5, 23–25]. In contrast, rOCT1 and
of cimetidine and rOCT2 protein expression rOCT2 transport cationic compounds such as tetraethyl-
If the decreased plasma concentration of testosterone ammonium, cimetidine, N1-methyl nicotinamide, guani-
is responsible for the renal expression level of rOCT2 dine, monoamines and procaineamide [20, 26, 27]. Kusu-
and the renal clearance of cimetidine in the 5/6 Nx rats, hara et al reported that a H2 blocker cimitidine, which
the exogenous administration of testosterone to the CRF is considered a good substrate for the classical organic
rats should lead to a recovery of the urinary excretion cation transport system, was also a substrate for rOAT3
of cimetidine as well as rOCT2 expression. To confirm [5]. Although various studies have demonstrated the
this hypothesis, we subcutaneously (SC) administered a physiological roles of these transporters, the pathophysi-
small amount of testosterone enanthate (0.5 mg/200 L/ ological alterations of these transporters in CRF have
rat/3 days) or vehicle (corn oil) for two weeks after sur- not been investigated.
Our previous study found that the expression of thegery. As shown in Table 5, the plasma concentration of
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Fig. 4. Protein expressions of rOAT1, rOAT3, rOCT1,
rOCT2 and Na/K-ATPase in sham-operated and
5/6 nephrectomized rats. Crude plasma membrane
fractions (25 g) from total kidneys were separated
by SDS-PAGE (10%) and blotted onto Immobilon
membranes. (A ) The antisera (1:1000 dilution) for
rOAT1 or rOAT3 was preabsorbed (Preabs) with
() or without () the antigen peptide (10 g/mL)
of rOAT1 or rOAT3, respectively. A horseradish
peroxidase-conjugated anti-rabbit IgG antibody was
used for detection of bound antibodies, and strips of
blots were visualized by chemiluminescence on
X-ray film. A 77 kD band for rOAT1 and a 72 kD
band for rOAT3 are seen (arrowheads). Blot of the
crude plasma membranes isolated from two indepen-
dent sham-operated rats are shown. (B ) Antisera
specific for rOAT1, rOAT3, rOCT1, rOCT2 and Na/
K-ATPase (1:500-1000 dilution) were used as pri-
mary antibodies. A horseradish peroxidase-conju-
gated anti-rabbit (for rOAT1, rOAT3, rOCT1 and
rOCT2) or anti-mouse (for Na/K-ATPase) IgG
antibody was used for detection of bound antibodies,
and strips of blots were visualized by chemilumines-
cence on X-ray film. Representative photographs of
three separate results of Western blotting are shown.
(C ) The protein bands are expressed in densitometry
units in () sham-operated and () 5/6 nephrecto-
mized rats. The values for sham rats were arbitrarily
defined as 100%. Each column represents the mean
SE of the six to seven rats in each group. **P 0.01,
significantly different from sham-operated controls.
luminal organic anion transporters, OAT-K1 and OAT-
K2, and the urinary secretion of methotrexate were de-
pressed in rats two weeks after 5/6 nephrectomy, despite
Table 4. Plasma levels of testosterone and 17-estradiol the minimal alterations in tubular morphology [28].
in sham and 5/6 Nx rats There was no significant difference in the basolateral
Sham 5/6 Nx uptake of methotrexate, which is considered to be medi-
ated by rOAT1 and rOAT3, between the sham-operatedTestosterone ng/mL 1.430.27 0.670.17a
17-Estradiol ng/mL 0.030.01 0.030.00 and 5/6 Nx rat kidneys. In the present study, the tissue
Each value represents the meanSE of twelve rats. Sham, sham-operated uptake clearances of PAH in the kidney cortex and me-
rats; 5/6 Nx, 5/6 nephrectomized rats.
aP  0.05, significantly different from sham-operated dulla were not significantly altered by 5/6 nephrectomy
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Table 5. Renal functional data and plasma levels of testosterone after administration of testosterone in rats
Sham T() Sham T() 5/6 Nx T() 5/6 Nx T()
Body weight g 2833.6 2786.8 23114.2b 2638.9
Urine volume mL/24 h 16.82.1 19.32.4 32.01.4b 34.32.3b
Pcr mg/dL 0.490.02 0.410.02a 1.420.29b 1.230.21b
Ccr mL/min/kg 4.240.61 5.730.73 1.510.26b 1.970.29b
BUN mg/dL 18.01.3 14.81.4 72.414.3b 62.412.4b
Testosterone ng/mL 1.990.24 4.520.48b 0.590.15b 3.020.56b,c
Values are meansSE of six to ten rats. PCr, plasma creatinine; CCr, creatinine clearance; BUN, blood urea nitrogen; Sham T (), sham-operated rats administrated
with vehicle; Sham T (), sham-operated rats administrated with testosterone, 5/6 Nx T (), 5/6 nephrectomized rats administrated with vehicle; 5/6 Nx T (), 5/6
nephrectomized rats administrated with testosterone.
aP  0.05, bP  0.01, significantly different from Sham T () rats
cP  0.01, significantly different from 5/6 Nx T () rats
Table 6. Pharmacokinetic parameters of cimetidine in infusion experiment after administration of testosterone in rats
Sham T() Sham T() 5/6 Nx T() 5/6 Nx T()
Cpss lmol/L 15716 16515 34018b 2687b,d
fu 0.890.02 0.880.02 0.850.04 0.840.04
Ctot mL/min/kg 18.91.6 17.71.2 9.00.3b 11.40.5b,d
Cren mL/min/kg 15.21.1 14.81.0 1.50.3b 4.50.6b,d
Cren of unbound fraction
mL/min/g kidney 2.70.3 2.70.2 0.60.1b 2.10.2d
Cren mL/min/g kidney 2.40.3 2.40.2 0.50.1b 1.80.2d
Kp 2.40.3 2.30.3 1.00.1b 1.60.2a,c
Cs mL/min/g kidney 2.10.2 2.00.2 0.10.0b 1.30.2a,d
Each value represents the meanSE of six rats. Cpss, plateau plasma concentration; Ctot, total clearance; Cren, renal clearance; fu, plasma unbound fraction; Kp,
tissue to plasma concentration ratio; Cs, renal secretory clearance; sham T (), sham-operated rats administrated with vehicle; Sham T (), sham-operated rats
administrated with testosterone, 5/6 Nx T (), 5/6 nephrectomized rats administrated with vehicle; 5/6 Nx T (), 5/6 nephrectomized rats administrated with
testosterone.
aP  0.05, bP  0.01, significantly different from Sham T () rats
cP  0.05, dP  0.01, significantly different from 5/6 Nx T () rats
(Table 3 and Fig. 3A). The expression levels of rOAT1 der membranes: a potential-sensitive transport system
and an anion exchanger [29]. However, the luminal PAHand rOAT3 protein were maintained in the 5/6 Nx rat
kidneys (Fig. 4 B, C). These observations and the present transporters have yet to be identified at the molecular
level. Therefore, the luminal PAH transporters may beresults suggested that the basolateral entry of organic
anions, especially substrates for rOAT1 and rOAT3, was cloned successfully by comparing the mRNA expression
profiles between sham-operated and 5/6 Nx rats.maintained at least two weeks after nephrectomy. There-
fore, the expression of the luminal OAT-K and basolat- Cimetidine is a substrate for rOAT3, rOCT1 and
rOCT2 [13]. In the present study, the renal clearance oferal OAT should be affected differently in CRF. As
highly accumulated anionic drugs such as methotrexate cimetidine was decreased to 19% of that in sham-oper-
ated controls (Table 2) and the distribution of cimetidinemay cause further deterioration of renal failure, the mo-
lecular mechanism(s) involved in the differential regula- into the kidney medulla was markedly depressed in the
5/6 nephrectomized rats (Table 3 and Fig. 3B). Westerntion of OAT-K and OAT expression should be elucida-
ted to prevent drug-induced nephrotoxicity under CRF. blotting revealed that the expression of rOCT2, but not
those of rOAT3 or rOCT1, was significantly decreasedTubular secretion is a vectorial transcellar transport
system consisting of basolateral entry into the epithelial in the 5/6 Nx rat kidneys (Fig. 4). The level of rOCT1
mRNA expression in the kidney cortex was higher thancells and secretion across the brush border membranes.
Defects in either of these two processes should influence that in the kidney medulla, and this message was abun-
dant in the S1 segment of proximal tubule [30]. In con-the tubular secretion of ionic drugs. In the present study,
the tubular secretion of PAH was markedly decreased trast, the rOCT2 mRNA expression in the kidney me-
dulla was higher than that in the kidney cortex, andto 44% in CRF rats, despite the maintained distribution
rate in the kidney (Figs. 1A and 3A). These results sug- rOCT2 protein was abundant in the proximal tubules of
the outer medulla [31]. These results strongly suggestedgested that the limiting step for the urinary excretion of
PAH might be the tubular secretion step across the brush that the rOCT2 localized in the proximal tubules of the
outer medulla plays a predominant role in the renalborder membranes. Two distinct transport systems were
demonstrated to transport PAH in rat renal brush-bor- distribution of cimetidine, and would be more sensitive
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Fig. 6. Protein expressions of rOAT1, rOAT3, rOCT1 and Na/K-
ATPase in sham-operated and 5/6 Nx rats after administration of
testosterone enanthate. Crude plasma membrane fractions (25 g)
from total kidneys were separated by SDS-PAGE (10%) and blotted
onto Immobilon membranes. Antisera specific for rOAT1, rOAT3,
rOCT1 and Na/K-ATPase (1:500-1000 dilution) were used as pri-
mary antibodies. A horseradish peroxidase-conjugated anti-rabbit (for
rOAT1, rOAT3, rOCT1) or anti-mouse (for Na/K-ATPase) IgG
antibody was used for detection of bound antibodies, and strips of blots
were visualized by chemiluminescence on X-ray film. Representative
photograph of separate three results of Western blotting are shown.
Abbreviations are: Sham, sham-operated rats; 5/6 Nx, 5/6 nephrecto-
mized rats; T(), rats administrated with vehicle; T(), rats adminis-
trated with testosterone.
lower serum testosterone level was reported to be associ-
Fig. 5. Effect of exogenous testosterone enanthate on rOCT2 protein ated with chronic renal failure [33, 34]. Abdel-Gawad et
expression (A), and correlation between the rOCT2 expression and the al [35] reported that in 5/6 nephrectomized rats 10 weeksrenal clearance of cimetidine in rats (B ). (A) Crude plasma membrane
after surgery the plasma concentration of testosteronefractions (25 g) from total kidneys were separated by SDS-PAGE
(10%) and blotted onto Immobilon membranes. Antisera specific for was decreased to below 30% of that in sham-operated
rOCT2 (1:1000 dilution) were used as primary antibodies. A horserad-
rats. In the present study, plasma concentration of testos-ish peroxidase-conjugated anti-rabbit IgG antibody was used to detect
bound antibodies, and strips of blots were visualized by chemilumines- terone appeared to be decreased in 5/6 nephrectomized
cence on X-ray film. Representative photograph of three separate rats two weeks after surgery and the expression level of
results of Western blotting are shown. (B) Correlation between the
rOCT2 protein was selectively down-regulated (Table 4rOCT2 protein expression and renal clearance of unbound cimetidine
are shown. The rOCT2 protein expression level was determined as and Fig. 4, respectively). The plasma concentrations of
outlined in the Methods section. Symbols are: () Sham T(), sham- testosterone in male and female rats were reported to
operated rats administrated with vehicle; () Sham T(), sham-oper-
be 1.5  0.03 and 0.25  0.02 ng/mL, respectively, andated rats administrated with testosterone enanthate; () 5/6 Nx T(),
5/6 nephrectomized rats administrated with vehicle; () 5/6 Nx T(), the level of rOCT2 protein expression in female rats was
5/6 nephrectomized rats administrated with testosterone enanthate. markedly lower than that in male rats [22]. These results
suggested that the decreased plasma testosterone was
one of the determinants of the down-regulation of
rOCT2 expression in 5/6 Nx rats.to renal damage than rOAT3 and rOCT1. To our knowl-
Because the plasma concentration of testosterone cor-edge, this is the first study demonstrating the responsibil-
related well with the renal rOCT2 expression [22], weity of rOCT2 for the urinary excretion of cimetidine in
hypothesized that the decreased renal clearance of cimet-vivo.
idine and the depressed expression level of rOCT2 inUrakami et al demonstrated that the expression of
the CRF rats could be ameliorated by the supplementaryrOCT2, but not of rOCT1 or rOAT1, was associated
treatment of testosterone. As expected, the administra-with the plasma concentration of testosterone [21]. The
tion of small amount of testosterone recovered the renalrenal expression level of rOCT2 in male rats was obvi-
clearance of cimetidine and the rOCT2 expression in theously higher than that in females. In addition, the OCT2
CRF rats to near the level of sham-operated rats (Tableexpression was up-regulated by treatment with testoster-
6 and Fig. 5A). Despite of the basolateral localization ofone, but not with estradiol, in rats and cultured Madin-
Darby canine kidney cells [22, 32]. In clinical cases, a rOCT2, the protein expression level of rOCT2 correlated
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plasma clearance; ELISA, enzyme-linked immunosorbent assay; fu,well with the renal clearance of cimetidine (r 	 0.96)
unbound fraction; GFR, glomerular filtration rate; HPLC, high perfor-
(Fig. 5B). However, it was confirmed that the protein mance liquid chromatography; Kp, tissue to plasma concentration ratio;
Nx, nephrectomy; OAT, organic anion transporter; OCT, organic cat-expression levels of the other basolateral transporters
ion transporter; PAH, paraaminohippurate; T, with () or () withoutrOAT1, rOAT1, rOAT3 and Na/K-ATPase were in-
testosterone enathate.
dependent of the plasma concentration of testosterone
(Fig. 6). These results indicated that the plasma concen-
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